Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Hospitals dominate the radiation dose management market, capturing approximately 50% of the share

  80% confidence

• 78% of U.S. hospitals have adopted AI-enabled dose monitoring software in response to the Joint Commission's 2024 imaging safety standards

  80% confidence

• By 2024, approximately 65% of U.S. hospitals had deployed advanced dose management solutions like Bayer's Radimetrics or GE HealthCare's DoseWatch

  80% confidence

• The software segment holds a commanding 70% share of the radiation dose management market

  80% confidence

• 78% of U.S. hospitals had deployed AI-powered dose management systems such as Bayer's Radimetrics and GE HealthCare's DoseWatch by 2024, reflecting a 25% increase in adoption since 2022

  80% confidence

• CT and MRI scans have increased by an average of 12% annually since 2020

  80% confidence

• 92% of hospitals accredited by the Joint Commission utilize automated dose tracking systems to adhere to the 2024 update of TJC Standard PC.01.03.01

  80% confidence

• Cardiac CT scans used for coronary artery screenings in Europe have surged by 25% between 2022 and 2024

  80% confidence

• United States accounts for approximately 75% of North America's radiation dose management market activity

  80% confidence

• Only 53% of outpatient centers have adopted automated dose tracking technologies

  80% confidence

• Software platforms have helped reduce protocol deviation errors by as much as 52%

  80% confidence

• United States and Germany together account for 45% of all AI-related patents in radiation dose management

  80% confidence

• The global radiation dose management market was valued at US$ 764.2 million in 2024 and is projected to hit the market valuation of US$ 2,301.3 million by 2033 at a CAGR of 13.03% during the forecast period 2025–2033

  80% confidence

• Medic Vision's FDA-cleared AI platform reduces fluoroscopy time during cardiac procedures by up to 30%

  80% confidence

• 68% of U.S. hospitals operate two or more CT scanners

  80% confidence